ABSTRACT
GABA is a major inhibitory neurotransmitter in the nervous system. It hyperpolarizes and therefore stabilizes most adult neurons by increasing Cl Ϫ conductance via activation of GABA A receptors. Attention to neuronal Cl Ϫ homeostasis has increased considerably, given the recently elucidated significance of Cl Ϫ pathways in several physiological processes and pathological conditions (1) (2) (3) (4) (5) (6) (7) (8) . An important class of these pathways is the cation-Cl Ϫ cotransporters (CCCs), which are electroneutral ion transporters coupling the movement of Cl Ϫ to Na ϩ and/or K ϩ fluxes across the plasma membrane (9 -11) . They are referred to as a secondary active transport mechanism, as they use gradients for Na ϩ or K ϩ created by the Na ϩ -K ϩ -ATPase pump. There are three main families of CCCs: the Na ϩ -Cl Ϫ (NCC) and Na ϩ -K ϩ -2Cl Ϫ (NKCC) families, which accumulate Cl Ϫ in the cell; and the K ϩ -Cl loop diuretic bumetanide is the most specific inhibitor of the cotransporter (15) (16) (17) , the reason that NKCC1 is also named bumetanide-sensitive cotransporter 2 (BSC2). Bumetanide binding to the cotransporter requires the simultaneous presence of Na ϩ , K ϩ , and Cl Ϫ , and the inhibition of the cotransporter is concentration dependent (13) , with maximal inhibition obtained after ϳ10 min of incubation (14) . Notably, the activity of NKCC1 is enhanced by the decrease in [Cl Ϫ ] i (11, 12, 15) . Moreover, NKCC1-mediated Cl Ϫ accumulation has been recently suggested to be under the control of a feedback mechanism that involves phosphorylation pathways (14, 18) . In addition, extracellular [Na ϩ ] and [K ϩ ] can also modulate NKCC1 activity (13) . Because NKCC1 is able to modify [Cl Ϫ ] i , it can substantially modulate GABAergic activity toward excitation or inhibition (16, 19 -22) . For instance, GABA is depolarizing in dorsal root ganglion neurons (DRGNs) and immature neurons mainly through high NKCC1 expression levels, whereas it has a hyperpolarizing effect in most adult neurons (7) (8) (9) (21) (22) (23) (24) . This GABA-induced excitation is an important feature of neurogenesis (25) . On the other hand, this unusual excitation renders the immature brain hyperexcitable and hence more susceptible to epileptic seizures (5) . Pharmacological inhibition of NKCC1 by bumetanide has even been proposed as a potential mechanism to be used in the treatment of neonatal seizures (26, 27) . In addition, NKCC1 has been suggested to play a role in many other pathological processes such as neurogenic inflammation (28) and brain ischemia (29) .
We have previously shown that rat cultured motor neurons (MNs) at embryonic day 14 (E14) display substantial and long-lasting [Cl Ϫ ] i changes (loading or depletion) when challenged with strong GABA stimulation at hyperpolarizing or depolarizing membrane potentials (30) . Recovery was faster after [Cl Ϫ ] i depletion than after [Cl Ϫ ] i loading, and NKCC1 cotransporters were suggested to contribute to the accelerated recovery, although their expression was assumed to be low. KCCs were probably not involved in the recovery process for several reasons. First, KCC1, KCC3, and KCC4 have limited expression in the nervous system (31) and are active under hypotonic conditions (32) . In addition, even if KCC2 has considerable activity under isosmotic conditions, its presence in DRGNs is controversial (6, 10, 33) , and the addition of Cs ϩ in the internal solutions prevents Cl Ϫ extrusion via KCC2 (34) .
In the present work, we studied intracellular chloride handling in E14 DRGNs and MNs in relation to the functional expression of NKCC1. We compared expression and cellular distribution of NKCC1 and studied its role in relation to [ 
MATERIALS AND METHODS

Cell culture
Both MNs and DRGNs were derived from E14 embryos of C57 black rats. MNs were prepared as described previously (35, 36) . In brief, the ventral spinal cord was dissected, cut in small pieces, trypsinized [0.05% of trypsin in Hanks' balanced salt solution (HBSS)] for 15 min at 37°C, and triturated. The MN population was purified by OptiPrep (6.2%) gradient centrifugation and seeded on a preestablished glial feeder layer. The culture medium (Life Technologies, Inc., Carlsbad, CA, USA) consisted of L15 medium supplemented with glucose (3.6 mg/ml), progesterone (20 nM), insulin (5 g/ml), putrescine (0.1 mM), conalbumin (0.1 mg/ml), sodium selenite (30 nM), penicillin (100 U/ml), streptomycin (100 g/ml), horse serum (2%), and chick embryo extract (5%). DRGN cells were prepared as described previously (37) . Briefly, DRGNs were dissected lateral to the dorsothoracic spinal cord, trypsinized (0.05% of trypsin in HBSS) for 10 min at 37°C, and triturated. They were purified by centrifugation at a relative centrifugal force of 75 for 20 min at 20°C using a 4% bovine serum albumin cushion and were seeded on poly-l-ornithine-and laminincoated glass coverslips at a density of 90,000 cells/ml. The DRGN culture medium was composed of Dulbecco's modified Eagle's medium (F12) supplemented with fetal calf serum (10%), penicillin (50 U/ml), streptomycin (50 g/ml), bicarbonate (0.045%), and nerve growth factor 2.5S (5-10 ng/ml). MNs and DRGNs were kept in a humidified incubator (7% CO 2 ) at 37°C and used between 3 to 12 days after plating.
Electrophysiology
GABA-induced currents (I GABA ) were recorded under voltage-clamp conditions using the gramicidin-perforated patchclamp technique (30) . The pipette solution contained 125 mM CsCl, 1.2 mM MgCl 2 , 10 mM HEPES, 2 mM Na 2 ATP, and 1 mM EGTA, and the pH was adjusted to 7.3 with CsOH. Gramicidin (Fluka AG, Buchs, Switzerland) was added to the pipette solution at concentrations of 87.5 and 75 g/ml for MNs and DRGNs, respectively. Patch pipettes with a resistance of ϳ3-5 M⍀ were briefly dipped in gramicidin-free pipette solution and backfilled with internal solution. After seal formation, access resistance was monitored until it reached a stable value of Յ30 M⍀. GABA was locally applied by using a fast perfusion system. The external solution, a modified Krebs' solution, contained 150 mM NaCl, 6 
Statistics and model simulations
All data are shown as means Ϯ se. Statistically significant differences were evaluated with an unpaired Student's t test (PϽ0.05). We used MATLAB version R14 Service Pack 3 (The MathWorks, Inc., Natick, MA, USA) to solve the differential equation describing the changes in [Cl Ϫ ] i (see Eq. 1 in the Discussion section). For this we used a variant of the built-in function "ode43" with a constant integration step of 1 s.
RESULTS
GABA-induced current responses were measured and analyzed in cultured E14 DRGNs (nϭ100) and MNs (nϭ70). DRGNs had a capacitance of 23 Ϯ 1 pF (nϭ80), which implied that the DRGN population was almost exclusively composed of small DRGNs (38 -40) of ϳ20 m in diameter ( Fig. 2C ) (39) . MNs had a higher capacitance of 41 Ϯ 2 pF (nϭ44), reflecting the extensive outgrowth of neurites in MNs, whereas DRGNs showed a small number of neurites ( Fig. 2C ) (22) .
First, we determined whether DRGNs and MNs displayed differences in GABA responsiveness and/or intracellular Cl Ϫ content. Figure 1A shows typical examples of GABA-induced currents at holding potentials in the range of Ϫ120 to ϩ50 mV. These currents were characterized by determining the maximum slope conductance, and reversal potentials were determined from I GABA -V relations (Fig. 1B) . Maximum slope conductance was significantly smaller in DRGNs (0.21Ϯ0.02 nS/pF; nϭ6) than in MNs (0.29 nS/pFϮ0.03; nϭ6). In addition, E Cl(GABA) values from DRGNs (Ϫ34Ϯ2 mV; nϭ58) were significantly more positive than those for MNs (Ϫ56Ϯ1 mV; nϭ43). These E Cl(GABA) values correspond to intracellular Cl Ϫ levels of 44 Ϯ 2 mM in DRGNs compared with 18 Ϯ 1 mM in MNs ( Fig. 2A) . To test whether the affinity of GABA A receptors for GABA was different between DRGNs and MNs, we determined GABA concentration-current response relationships (Fig.  1D) . Fitting of the experimental data with a Hill equation yields rather similar estimates for the effective concentration and Hill coefficient in DRGNs (EC 50 ϭ74Ϯ8 M; n H ϭ0.71Ϯ0.04; nϭ6) and MNs (EC 50 ϭ40Ϯ12 M; n H ϭ0.63Ϯ0.07; nϭ6).
It has been shown that the high intracellular Cl Ϫ level found in mature DRGNs is related to a high expression level of NKCC1 cotransporters in these cells (7, 16, 23) . In accordance with this finding, we observed that application of 10 M bumetanide, a selective NKCC1 blocker (9, 11, 16, 17) (Fig. 2A) . In addition, when neurons were preincubated for 30 min in low external Na ϩ medium, which inhibits Cl Ϫ entry via NKCC1 (41), the resting [Cl Ϫ ] i dropped significantly in DRGNs (36%, nϭ6), whereas the decrease in MNs was not statistically significant (12%, nϭ5) ( Fig. 2A) .
The expression of NKCC1 in DRGNs and MNs was confirmed by Western blot using the monoclonal anti-NKCC1 (T4) antibody. No clear difference in expression levels was observed between the two cell types (data not shown). In addition, immunocytochemistry experiments with the same antibody confirmed a previous report (41) showing that DRGNs showed high NKCC1 expression levels all over the cell, whereas in MNs NKCC1 was localized mainly in the neuronal expansions (data not shown).
We have shown previously that prolonged application of GABA associated with membrane hyperpolarization or depolarization induces long-lasting changes in intracellular Cl Ϫ levels in motor neurons (30) . It is known that NKCC1 is mainly a Cl Ϫ uptake mechanism, as it only supports Cl Ϫ efflux at very high intracellular concentrations (ϳ100 mM) of this ion (11) . Therefore, we hypothesized that this cotransporter should not have a strong influence in the recovery of [Cl Ϫ ] i after loading. On the other hand, a higher functional expression of NKCC1 in DRGNs should result in faster recovery of [Cl Ϫ ] i after depletion when compared with that in MNs. . B) Examples of I-V curves obtained during application of voltage ramps from Ϫ100 to ϩ50 mV at peak of the GABA-activated current in DRGNs (500 M GABA) and MNs (50 M GABA). Normalized chord conductance and GABA equilibrium potential were 0.24 nS/pF and Ϫ32 mV and 0.39 nS/pF and Ϫ51 mV for DRGNs and MNs, respectively. C) GABA dose-response curves for DRGNs and MNs.
To assess the role of NKCC1 in relation to intracellular chloride dynamics, we used the following experimental procedure. In control conditions, I GABA was elicited by applying a standard stimulation protocol in which DRGNs were held at Ϫ40 mV and MNs at Ϫ60 mV, and GABA was applied for 1 s every 30 s at the concentrations of 500 M in DRGNs and 50 M in MNs. For each cell type, the holding potentials were chosen to be close to their equilibrium potential for chloride. After three stimuli, cells were loaded with Cl Ϫ by applying a strong depolarization in the presence of GABA at high concentration. For this, DRGNs were depolarized to ϩ70 mV and MNs to ϩ50 mV for 10 s while being perfused Fig. 3A, B, E .3 min; nϭ6) . Notably, the recovery was severely hindered by decreasing the frequency of stimulation of GABA receptors, indicating that the changes in [Cl Ϫ ] i after loading occurred mainly via Cl Ϫ efflux through I GABA . In addition, the recovery was not altered by preincubation of the cells in a medium with a low Na ϩ concentration ( Fig. 3C-E) , a maneuver that is known to decrease the activity of NKCC1 (41) . Altogether, these observations indicate that after loading NKCC1 is not involved in the decrease of [Cl Ϫ ] i to the resting level. To test whether NKCC1 is involved in the recovery ([Cl Ϫ ] i increase) after depletion we used a protocol similar to that used for testing the effects of loading. To induce intracellular chloride depletion DRGNs were hyperpolarized to Ϫ100 mV and MNs to Ϫ120 mV for 10 s while being perfused during 5 s with GABA at 1. DRGNs. In contrast, MNs showed low intracellular Cl Ϫ accumulation in basal conditions, a fact that most likely reflects low NKCC1 activity in these cells (2, 30) . In accordance with the effects of bumetanide, preincubation of the cells in a low Na ϩ solution medium, which reduces the activity of NKCC1 (41) In contrast to loading, depletion was able to reveal the role of NKCC1 in the kinetics of intracellular chloride handling. Indeed, the [Cl Ϫ ] i increase after depletion was significantly faster in DRGNs than in MNs, a difference that was absent when NKCC1 was inhibited by preincubation of the cells in a low Na ϩ solution.
Overall, these observations constitute strong evi- dence for a higher functional expression of NKCC1 in DRGNs with respect to MNs. Still, it could be argued that the disparity in depletion conditions between DRGNs and MNs could somehow account for the differences in recovery between these cells. It seems clear that the recovery ([Cl Ϫ ] i increase) after depletion in DRGNs can only be attributed to secondary active Cl Ϫ uptake, most probably through NKCC1, because during the recovery phase I GABA was always inward (corresponding to passive Cl Ϫ loss). However, understanding the recovery from depletion in MNs seems to be harder, as during the early phase of the recovery I GABA was directed outward and contributed to the passive Cl Ϫ accumulation. In contrast, in later recovery this current was directed inward and therefore contributed to Cl Ϫ depletion. 
where I GABA (t) is the GABA-induced current, I BCl is the current through a linear background Cl Ϫ pathway, F is the Faraday constant, and J NKCC1 is the number of moles of chloride moved across the membrane per second by the NKCC1 cotransporter. As first approximation, this model assumes that intracellular Cl Ϫ is distributed in a single compartment of volume V Cl (intracellular Cl Ϫ -handling volume). This volume is anticipated to be smaller than the actual cell volume, given that Cl Ϫ is not expected to diffuse into all intracellular compartments. The expressions used to calculate the terms I GABA (t), I BCl , and J NKCC are given in the Appendix. To reproduce the experimental data, only three parameters were varied: the chloride handling volume, the conductance for chloride background current, and the maximal rate of transport through NKCC1 (see Appendix).
As shown in Fig. 5A , B, the model closely reproduces the time course of the [Cl Ϫ ] i increase after depletion for both DRGNs and MNs (compare with Fig. 4A, B) . The time constants of recovery obtained with the model were equal to 1 and 1.57 min for DRGNs and MNs, respectively. These values are very close to those obtained experimentally (ϭ0.9Ϯ0.1 and 1.6Ϯ0.1 min for DRGNs and MNs, respectively). Notably, to simulate the experimental data it was necessary to consider that the maximal rate of transport of NKCC1 was 37.5-fold higher in DRGNs than in MNs (see Fig. 5C-F [Cl Ϫ ] i . In DRGNs, these pathways always cause Cl Ϫ depletion (Fig. 5A, C, E) . However, in MNs they cause loading during the early phase of the [Cl (Fig. 5B, D) , which is manifested as a "bump" in the corresponding curves of cumulative change of [Cl Ϫ ] i (Fig. 5F) . Altogether, the model is in full agreement and gives further support to the experimental data, indicating that there is a higher functional expression of NKCC1 in DRGNs with respect to MNs. Yet, when one considers that NKCC1 is also expressed in MNs (Fig. 2B, C) , it remains unclear why the experiments and the model simulations indicate that activity of NKCC1 is much higher in DRGNs than in MNs. When this point is analyzed, it is important to take into account the fact that cells were patched at the soma, and, therefore, the kinetics of intracellular Cl Ϫ changes are expected to reflect mainly the activity of chloride membrane pathways in this region. Events occurring in the dendritic extensions were probably misrepresented in the experimental observations because of restricted diffusion and electrical access. Hence, the contrast between the rather homogeneous expression of NKCC1 in DRGNs and the almost exclusive location of this cotransporter in the dendritic regions of MNs fits with a larger contribution of NKCC1 to the intracellular (somatic) Cl Ϫ handling in DRGNs. However, different somatic expressions of NKCC1 in DRGNs and MNs might not fully explain the remarkable discrepancy noticed in NKCC1 activity. Differences in NKCC1 activation levels could also account for it. Although we did not systematically monitor cell volume changes during our experiments, NKCC1 activation by cell shrinkage (32, 43) could also be involved. In this perspective, the crucial role of the cytoskeleton via F-actin, myosin II, and myosin light-chain kinase was shown in several studies (44 -47) . Figure 5C , D shows that the model also complies with the changes in [Cl Ϫ ] i and Cl Ϫ equilibrium potential observed in the depletion experiments. This was accomplished by adjusting the value of the intracellular Cl Ϫ -handling volume V Cl . In DRGNs, V Cl ϭ 1.3 pl, which is lower than the values obtained for MNs (V Cl ϭ3.6 pl). This difference is in agreement with the higher membrane capacitance we have observed in MNs with respect to DRGNs.
It has been reported that NKCC1 is down-regulated in the perinatal period in the central nervous system (8, 48) and the spinal cord (49) , which results from the action of maternal oxytocin during birth (50 (4) give rise to serious impairments in sensory perception (1, 6) . We should, of course, be cautious in extrapolating data from embryonic cultured DRGNs to adult neurons in vivo. However, resting [Cl Ϫ ] i in cultured E14 DRGNs is not different from that found in mature cells (7, 16, 22, 23) .
